Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saravanan Rajan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal for Immunotherapy of Cancer|April 17, 2025
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunityDes C Jones, Lorraine Irving, Rebecca Dudley, et al.
Science Translational Medicine|June 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adultsYingyun Cai, Seme Diallo, Kim Rosenthal, et al.
Science Advances|March 28, 2025
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escapeFangqiang Zhu, Saravanan Rajan, Conor F Hayes, et al.
Structure (London, England : 1993)|December 29, 2023
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domainRajeshwer S Sankhala, Vincent Dussupt, Wei-Hung Chen, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal for Immunotherapy of Cancer|April 17, 2025
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunityDes C Jones, Lorraine Irving, Rebecca Dudley, et al.
Science Translational Medicine|June 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adultsYingyun Cai, Seme Diallo, Kim Rosenthal, et al.
Science Advances|March 28, 2025
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escapeFangqiang Zhu, Saravanan Rajan, Conor F Hayes, et al.
Structure (London, England : 1993)|December 29, 2023
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domainRajeshwer S Sankhala, Vincent Dussupt, Wei-Hung Chen, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Pageof 2